Immunology Activities
Biosimilars: A Managed Care Update of Real-World Evidence and Cost-Savings Data When Treating Inflammatory Conditions
0290-0000-20-203-L01-P
This live activity will identify the patient populations with rheumatic and inflammatory disease and consider the biologic costs associated with pharmacologic treatment.
9-29-2020
1.00
Influenza Treatment: Exploring the Clinical and Economic Benefits of Antivirals
0290-0000-20-142-H01-P
This activity will distinguish the patient populations at high risk for influenza-related complications.
1.50
Primary Immunodeficiency Disorder: Considerations in the Use of Intravenous and Subcutaneous Immunoglobulin
0290-0000-20-132-H01-P
This activity will provide practice pearls for specialty pharmacists to improve care for those affected by PID.
1.50
Reviewing Interleukin 17— and Interleukin 23—targeting Therapies and Best Practices in Psoriatic Disease Management Feat. Clinical Practice Video Vignettes
0290-0000-20-043-H01-P
This activity includes patient counseling videos that highlight the vital roles of specialty pharmacists in assisting patients with PsO and PsA via clinical interventions, educating patients about administration, and monitoring patient response and adherence to selected therapy.
2.00